Breast Cancer: Targets and Therapy
Volume 16, 2024 - Issue
ORIGINAL RESEARCH
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
, , 
, , , , & show all
Weidong Li2 Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, People’s Republic of China;4 Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of Chinahttps://orcid.org/0000-0002-1168-3498View further author information
https://orcid.org/0000-0002-1168-3498View further author information, , Li Zhang1 Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;2 Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, People’s Republic of Chinahttps://orcid.org/0000-0002-8412-0936View further author information
https://orcid.org/0000-0002-8412-0936View further author information, , & Zhongsheng Tong1 Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;2 Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, People’s Republic of Chinahttps://orcid.org/0000-0001-8060-5699View further author information
https://orcid.org/0000-0001-8060-5699View further author information show all